A Phenotypic Screening Technology Aimed at Drugging Undruggable Targets
Date and Time
February 23, 2016
02:00PM - 03:00PM EST
Location
Dana-Farber Cancer Institute, Yawkey 308, 450 Brookline Avenue, Boston, MA
Guest speaker:
Chris Torrance, PhD
CEO and Co-founder
PhoreMost, Ltd.
Cambridge, UK